PDCD1 and non-small cell lung carcinoma: Besides, in terms of the cohort of Chinese NSCLC patients, Jin et al. investigated the interrelationship between the gut microbiota configuration and anti-PD1 blockade efficacy, illustrating another distinct bacterial make-up in well responders, consisting of Alistipes putredinis, Bifidobacterium longum, and Prevotella copri (Figure 1A) (23).